Biotricity Inc Revenue Growth Rates (BTCY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biotricity Inc   (BTCY)
 

BTCY's Revenue Growth by Quarter and Year

Biotricity Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BTCY Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter March -
3rd Quarter December 3.99
2nd Quarter September 3.89
1st Quarter June 3.87
FY 11.75

BTCYs Annual Revenue
Biotricity Inc 's Revenue in the fiscal year 2025 $ 13.56 millions
Biotricity Inc 's Revenue in the fiscal year 2024 $ 11.36 millions
Biotricity Inc 's Revenue in the fiscal year 2023 $ 9.64 millions
Biotricity Inc 's Revenue in the fiscal year 2022 $ 7.65 millions
Biotricity Inc 's Revenue in the fiscal year 2021 $ 3.38 millions




BTCY Revenue third quarter 2026 Y/Y Growth Comment
Biotricity Inc reported Revenue increase of 10.16% year on year in the third quarter 2026, to $ 3.99 millions, this is lower than Biotricity Inc 's recent average Revenue rise of 78.72%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 26 other companies have achieved higher Revenue growth. While Biotricity Inc ' s Revenue growth of 10.16% ranks overall at the positon no. 484 in the third quarter 2026.


BTCY Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter March - 9.43 % 29.27 % 27.46 %
3rd Quarter December 10.16 % 21.89 % 24.79 % 31.49 %
2nd Quarter September 18.96 % 11.99 % 41.75 % 17.05 %
1st Quarter June 20.94 % 16.79 % 27.44 % 80.67 %
FY   - 14.9 % 30.5 % -

Financial Statements
Biotricity Inc 's third quarter 2026 Revenue $ 3.99 millions BTCY's Income Statement
Biotricity Inc 's third quarter 2025 Revenue $ 3.62 millions Quarterly BTCY's Income Statement


BTCY Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter March - -3.87 % 7.07 % 3.36 %
3rd Quarter December 2.51 % 10.7 % 1.71 % 15.53 %
2nd Quarter September 0.52 % 2.19 % 6.57 % -4.19 %
1st Quarter June 11.21 % 0.63 % 11.38 % 11.4 %
FY (Year on Year)   - 14.9 % 30.5 % -


Back to BTCY Growth rate Comparisons >> Back to BTCY Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #27
Healthcare Sector #55
Overall #484

Revenue Y/Y Growth Statistics
High Average Low
256.03 % 78.72 % 16.26 %
(Mar 31 2020)   (Dec 31 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #27
Healthcare Sector #55
Overall #484
Revenue Y/Y Growth Statistics
High Average Low
256.03 % 78.72 % 16.26 %
(Mar 31 2020)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Biotricity Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
379.95 % 30 % -4.97 %
(Sep 30 2018)  


BTCY's III. Quarter Q/Q Revenue Comment
Biotricity Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.51% quarter on quarter, to $ 3.99 millions.

Within Medical Equipment & Supplies industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Biotricity Inc 's Revenue growth quarter on quarter, overall rank is 449.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #22
Healthcare Sector #57
Overall #449
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #22
Healthcare Sector #57
Overall #449
Revenue Q/Q Growth Statistics
High Average Low
379.95 % 30 % -4.97 %
(Sep 30 2018)  


BTCY's III. Quarter Q/Q Revenue Comment
Biotricity Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.51% quarter on quarter, to $ 3.99 millions.

Within Medical Equipment & Supplies industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Biotricity Inc 's Revenue growth quarter on quarter, overall rank is 449.


Biotricity Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)
Cumulative Revenue 12 Months Ending $ 15.22 $ 14.86 $ 14.24 $ 13.56 $ 13.27
Y / Y Revenue Growth (TTM) 14.76 % 17.72 % 16.03 % 14.85 % 19.61 %
Year on Year Revenue Growth Overall Ranking # 969 # 645 # 415 # 424 # 407
Seqeuential Revenue Change (TTM) 2.48 % 4.35 % 4.96 % 2.25 % 5.12 %
Seq. Revenue Growth (TTM) Overall Ranking # 484 # 1790 # 1635 # 1625 # 1560


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2025 period, Biotricity Inc 's cumulative twelve months Revenue were $ 15 millions, company would post below average annual Revenue growth of 5.12% year on year, if the fiscal year would end at Dec 31 2025.
A slow-down in the Biotricity Inc 's Revenue growth from the 3.89% growth in Sep 30 2025.

In the Healthcare sector 195 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 645 to 969.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 196
Overall # 969

Revenue TTM Y/Y Growth Statistics
High Average Low
256.03 %
 78.72 %
16.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 55
S&P 500 # 484
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2025 period, Biotricity Inc 's cumulative twelve months Revenue were $ 15 millions, company would post below average annual Revenue growth of 16.26% year on year, if the fiscal year would end at Dec 31 2025.
A slow-down in the Biotricity Inc 's Revenue growth from the 3.89% growth in Sep 30 2025.

In the Healthcare sector 195 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 645 to 969.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 196
Overall # 969

Revenue TTM Y/Y Growth Statistics
High Average Low
256.03 %
78.72 %
16.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 55
S&P 500 # 484




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BTCY's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Iovance Biotherapeutics inc 17.74%$ 17.745 millions
Si bone inc 17.59%$ 17.586 millions
Krystal Biotech Inc 17.52%$ 17.517 millions
Lifestance Health Group Inc 17.43%$ 17.425 millions
Privia Health Group Inc 17.42%$ 17.417 millions
Iradimed Corporation17.03%$ 17.034 millions
Biomarin Pharmaceutical Inc17.03%$ 17.028 millions
Zai Lab Limited16.99%$ 16.986 millions
Twist Bioscience Corporation16.89%$ 16.892 millions
Fortress Biotech Inc 16.38%$ 16.376 millions
Orthopediatrics Corp15.95%$ 15.945 millions
Concentra Group Holdings Parent Inc 15.92%$ 15.921 millions
Boston Scientific Corporation15.90%$ 15.896 millions
Electromed Inc 15.77%$ 15.774 millions
Evolus Inc 15.64%$ 15.636 millions
Lemaitre Vascular Inc 15.20%$ 15.197 millions
Envista Holdings Corporation15.01%$ 15.011 millions
Radnet Inc 14.80%$ 14.800 millions
Innovage Holding Corp 14.69%$ 14.693 millions
Kamada Ltd 14.54%$ 14.544 millions
Idexx Laboratories Inc14.40%$ 14.398 millions
Cerus Corporation14.33%$ 14.331 millions
Grail Inc 13.97%$ 13.973 millions
Dr Reddy s Laboratories Limited13.76%$ 13.761 millions
Pacific Biosciences Of California Inc 13.75%$ 13.750 millions
Dexcom Inc 13.19%$ 13.189 millions
Atricure Inc 13.05%$ 13.054 millions
Collegium Pharmaceutical Inc 12.92%$ 12.916 millions
Inspire Medical Systems inc 12.58%$ 12.577 millions
Qhslab Inc 12.43%$ 12.433 millions


About Biotricity Inc Revenue Growth Rates (BTCY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Biotricity Inc (CIK 1630113).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-039209
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Biotricity Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.